These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 5925687)

  • 1. [On 5-fluorouracil treatment of advanced gynecologic carcinomas].
    Lutziger H; Berger M
    Gynaecologia; 1966; 161(2):164-71. PubMed ID: 5925687
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of advanced breast cancer with cyclophosphamide, methotrexate, 5-fluorouracil and prednisone (CMFP)].
    Rabinovich MG; Leone BA; Landó O
    Medicina (B Aires); 1981; 41(1):65-70. PubMed ID: 7266359
    [No Abstract]   [Full Text] [Related]  

  • 3. [Chemotherapy of malignant gynecologic neoplasms].
    Huber R; Lau HU
    Zentralbl Gynakol; 1970 Jul; 92(30):966-70. PubMed ID: 5477142
    [No Abstract]   [Full Text] [Related]  

  • 4. [Combination chemotherapy of cyclophosphamide adriamycin and 5-fluorouracil (CAF) in advanced and recurrent breast cancer].
    Abe O; Izuo M; Enomoto K; Kubo K; Koyama H; Sakai K; Terasawa T; Tominaga T; Nomura Y
    Gan To Kagaku Ryoho; 1982 May; 9(5):866-73. PubMed ID: 7184431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The hormonal influence in gynecologic oncology].
    Uyttenbroeck F
    Verh K Acad Geneeskd Belg; 1981; 43(1):14-46. PubMed ID: 7293393
    [No Abstract]   [Full Text] [Related]  

  • 6. Chemotherapy for lymphatic metastatic gynecologic cancer via pelvic retroperitoneal cannulation: a preliminary report.
    Zeyi C; Zongbing Y; Shiying Z; Zhilan P; Jinghua W; Peiyi L
    Gynecol Oncol; 1996 Dec; 63(3):358-63. PubMed ID: 8946872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitomycin C and 5-fluorouracil as second choice treatment in advanced breast cancer patients.
    Ardizzoni A; Pronzato P; Conte PF; Rosso R
    Chemioterapia; 1984 Apr; 3(2):83-5. PubMed ID: 6442624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Long term continuous combination of cisplatin and 5 fluorouracil in advanced breast neoplasms. A retrospective study of 77 patients].
    Spaeth D; Conroy T; Krakowski I; Geoffrois L; Luporsi E; Rios M; Weber B
    Bull Cancer; 1993 Apr; 80(4):351-6. PubMed ID: 8173188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Results of "5-drug" treatment of advanced breast cancer].
    Dorociak R
    Pol Tyg Lek; 1981 Sep; 36(38):1467-70. PubMed ID: 7329862
    [No Abstract]   [Full Text] [Related]  

  • 10. Management of cancer-related anemia in patients with breast or gynecologic cancer: new insights based on results from the European Cancer Anemia Survey.
    Barrett-Lee P; Bokemeyer C; Gascón P; Nortier JW; Schneider M; Schrijvers D; Van Belle S;
    Oncologist; 2005 Oct; 10(9):743-57. PubMed ID: 16249356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapy for advanced breast cancer.
    Khanna NN; Kumar A; Khanna S; Pant GC; Sanyal B
    Indian J Cancer; 1981 Mar; 18(1):59-62. PubMed ID: 7262908
    [No Abstract]   [Full Text] [Related]  

  • 12. [The combination of thio-tepa and 5 fluorouracil as a palliative therapy for breast cancer].
    Chauvergne J; Hoerni B; Hoerni-Simon G; Durand M
    Rev Fr Gynecol Obstet; 1973 Mar; 68(3):159-65. PubMed ID: 17472211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methotrexate, mitoxantrone, 5-fluorouracil and leucovorin in metastatic breast cancer patients.
    Merlini L; Secondo V; Mammoliti S; Bellotti P; Castello C; Gallo L
    Anticancer Res; 1994; 14(3B):1423-6. PubMed ID: 8067717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Advanced carcinoma of the breast. Results of a polychemotherapeutic protocol].
    Fazio M; Manca A; Rodino A; Cavallero P; Tripodina A
    Minerva Ginecol; 1982 Sep; 34(9):667-70. PubMed ID: 7145204
    [No Abstract]   [Full Text] [Related]  

  • 15. New approaches to breast cancer: oxaliplatin combined with 5-fluorouracil and folinic acid in pretreated advanced breast cancer patients: preliminary reports.
    Leonardi V; Savio G; Laudani A; Blasi L; Agostara B
    Ann N Y Acad Sci; 2002 Jun; 963():91-7. PubMed ID: 12095933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thymidine and 5-FU: a Phase II pilot study in colorectal and breast carcinomas.
    Presant CA; Multhauf P; Klein L; Chan C; Chang FF; Hum G; Joseph R; Opfell R; Lemkin S; Shiftan T; Plotkin D
    Cancer Treat Rep; 1983; 67(7-8):735-6. PubMed ID: 6871891
    [No Abstract]   [Full Text] [Related]  

  • 17. Proceedings of the symposium, Monoclonal antibodies in gynecologic oncology.
    Eur J Obstet Gynecol Reprod Biol; 1985 Jun; 19(6):339-64. PubMed ID: 4018371
    [No Abstract]   [Full Text] [Related]  

  • 18. Phase II trial of a combination of vinorelbine, cyclophosphamide and 5-fluorouracil in the treatment of advanced breast cancer.
    Ardavanis A; Extra JM; Espié M; Cuvier C; Marty M
    In Vivo; 1998; 12(5):559-62. PubMed ID: 9827368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison of the therapeutic effect of CMxMF and CAMF regimens in the management of advanced breast cancer patients].
    Chen JA
    Zhonghua Zhong Liu Za Zhi; 1993 May; 15(3):202-4. PubMed ID: 8261866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tamoxifen and conjugated estrogens (Premarin) followed by sequenced methotrexate and 5-FU in refractory advanced breast cancer.
    Eisenhauer EA; Bowman DM; Pritchard KI; Paterson AH; Ragaz J; Plenderleith I; Geggie PH; Maxwell I
    Cancer Treat Rep; 1984 Nov; 68(11):1421-2. PubMed ID: 6094005
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.